1.A Case of Kimura's Disease.
Myung Yol KIM ; Yoo Shin LEE ; Hyung Jai KANG
Korean Journal of Dermatology 1975;13(3):243-247
A case of Kimuras disease was presented. It seemed that this is the first reported case in Korean literature. The patient was 26 years old male having painless slowly growing tumor-like swelling on his left cheek for 5 months. Mild leukocytosis and marked eosinophilia (27%) were noted in routine laboratory tests. Histopathologically numerous well developed lymphoid follicular structures composed of closely packed lymphocytes and histiocytes were seen in the deep dermis and subcutaneous fat tissue. Dense eosinophilic infiltrations in and around the follicles were peculiar picture. The literature was reviewed. Its relation to the similar descriptions in western literature under various diffe'rent headings was discussed;
Adult
;
Cheek
;
Dermis
;
Eosinophilia
;
Eosinophils
;
Head
;
Histiocytes
;
Humans
;
Leukocytosis
;
Lymphocytes
;
Male
;
Subcutaneous Fat
2.A Case of Cutis Marmotata Telangiectatica Congenita.
Myung Yol KIM ; Chang Woo LEE ; Yoo Shin LEE
Korean Journal of Dermatology 1975;13(4):311-314
Cutis marmirata telangiectatica congenita, first described by van Lohuizen in 1922, is a rare congenital vascular anomaly. This name is still generally used in Europe, but in American literature the most comrnon designation for this disease is generalized congenital phlebectasia. We represent the first reported case of cutis marmorata telangiectatica, congenita in Korea. The patient, 8 months old boy, has generalized cutis marmorata-like reticulated mottlings on his entire skin except the rnucous membranes since birth. He also has complete cleft palate but no other detectable congenital vascular malformation. The skin lesion shows spontaneous gradual improvement from three months of age.
Cleft Palate
;
Europe
;
Humans
;
Infant
;
Korea
;
Male
;
Membranes
;
Parturition
;
Skin
;
Vascular Malformations
3.Clinical and Histopathologic Observation in Patients with Lichen Striatus.
Sook Ja SON ; Won Suk KIM ; Myung Yol KIM ; Yoo Shin LEE
Korean Journal of Dermatology 1976;14(2):107-114
Lichen striatus is an uncommon nonspecific inflammatory cutaneous disease of unknown etiology occuring as unilateral and linear distribution on extremities and healing spontaneously within a few months to a year. Clinically it is composed of small licbenoid papules which tend to be grouped and coalesced to form either a continuous or an interrupted hypopigmented band and is not usually accompanied by any subjective symptoms. The principal histologic features are an infiltrate composed of lymphocytes and histiocytes around papillary vessels and usually also around, some of the deeper vessels and skin appendages and consequent secondary changes of the epidermis. We present the results of clinical and histopathologic observation in 19 patients with lichen striatus observed at Department of Dermatology, National Medical Center and Seoul National University Hospital during 4 years period from l972 to 1976 which would be the first recorded report on this rare disease in Korea. 1. Clinieal Observation.' Among the 19 patients, 10 were female and 9 were male; 15 were under 10 years of age and 4 were over 10 years of age. Duration of the eruption varied from 1 week to 4 years and average duration was 9.6 months at the time of the first visit. It was unilateral in all cases and affected the upper extremities in 9 and the lower extremities in 8 instances. The eruption extended onto the upper part of the trunk in 2 cases. Only 3 patients had a history of mild intermittent itching sensation. Characteristically, the eruption consisted of grouped, linear, slightly scaling flat polygonal papules with varying degrees of hypopigmentation, extending at least onethird of the length of an extremity. . Histopathologic observation: Skin biopsy was performed in 13 cases. The epiderrnal changes consist of mild diffuse hyperkeratosis (13 cases), focal parakeratosis (5 cases), varying degree of atrophy of malpighian layer (7 cases), mild acanthosis (2 cases), intercellular and intracellular edema (8 cases), exocytosih of lymphocytes (7 cases), focal basal cell disruption (11 cases), and dyskeratotic cells (colloid body) (2 cases). Dermal changes include mild to moderate perivaacular lymphocytic and histiocytic infiltrate rnostly on the level of papillary dermis. Also, there was chronic infIammatory cell infiltrate around hair follicle and sweat glands and ducts in 7 cases respectively, which seems to be peculiar in this disease. Overall histologic findings in our cases are generally consistent with those of the primary phase of the so-called lichenoid tissue reaction of Pinkus, The possible pathogenetic mechanism of the linear eruption and immunobiologic interpretation of the lichenoid tissue reaction were literally reviewed.
Atrophy
;
Biopsy
;
Dermatology
;
Dermis
;
Edema
;
Epidermis
;
Extremities
;
Female
;
Hair Follicle
;
Histiocytes
;
Humans
;
Hypopigmentation
;
Korea
;
Lichens*
;
Lower Extremity
;
Lymphocytes
;
Male
;
Parakeratosis
;
Pruritus
;
Rare Diseases
;
Sensation
;
Seoul
;
Skin
;
Sweat Glands
;
Upper Extremity
4.Analgesic Effect of Epidural Fentanyl-Neostigmine after Radical Subtotal Gastrectomy.
Se Yol KIM ; Myung Ha YOON ; Seok Jai KIM ; Sung Tae CHUNG
Korean Journal of Anesthesiology 2007;53(2):217-221
BACKGROUND: This study evaluated the efficacy of an epidural single dose of neostigmine combined with fentanyl to provide postoperative analgesia after radical subtotal gastrectomy. METHODS: Fifty two adults patients with ASA physical status 1 and 2 are randomly allocated to receive a single injection of either epidural fentanyl 100 microgramor combination of fentanyl 100microgram with neostigmine 250, 500 and 750microgramin a total volume of 10 ml. Pain scores were recorded after 0, 5, 10, 15, 20, 30 mins to determine the onset of analgesia. Patients' vital signs as well as side effects were monitored at regular intervals. RESULTS: Patients' demographic data were not different from each other. Epidural neostigmine 750 microgram with fentanyl 100 microgram produced effective analgesia (visual analog scale at 10 min ; 35 +/- 10.6 mm). The time to first rescue analgesics administration was significantly longer in the neostigmine group (250 microgram: 84.2 +/- 9.4, 500 microgram: 90.9 +/- 7.1, 750 microgram: 92.5 +/- 14.4 min) than the control group (53.0 +/- 20.0 min). CONCLUSIONS: Combination of fentanyl with neostigmine was proven to be more effective for treating postoperative pain after subtotal gastrectomy than fentanyl alone. Additionally, the most effective dose of epidural neostigmine was 750microgram.
Adult
;
Analgesia
;
Analgesics
;
Fentanyl
;
Gastrectomy*
;
Humans
;
Neostigmine
;
Pain, Postoperative
;
Vital Signs
5.Duloxetine versus Placebo for the Treatment of Korean Women with Stress Predominant Urinary Incontinence.
Sang Yol MAH ; Kyu Sung LEE ; Myung Soo CHOO ; Ju Tae SEO ; Jeong Zoo LEE ; Won Hee PARK ; Joon Chul KIM ; Seung Yun LEE ; Yan Daniel ZHAO ; Julie BEYRER ; Meghan WULSTER-RADCLIFFE ; Louise LEVINE ; Lars VIKTRUP
Korean Journal of Urology 2006;47(5):527-535
PURPOSE: To compare duloxetine with placebo for the treatment of Korean women with stress urinary incontinence (SUI). MATERIALS AND METHODS: This was a phase 3, double-blind, stratified, randomized, parallel, placebo-controlled, multi-center study investigating efficacy and safety of a of duloxetine compared with placebo in the treatment of SUI. After a 2-week no-drug screening period, women ages 29-69 were randomly assigned to placebo (n=60) or duloxetine (n=61) as 40mg twice daily for 8 weeks followed by a 2 week no-drug period. Women were seen at 4-week intervals. The primary efficacy variable was percent change in incontinence episodes frequency (IEF)/week. Secondary variables included percent change in, changes in Incontinence Quality of Life (I-QoL) total and 3 sub-scale scores, and Patient Global Impression of Improvement (PGI-I) ratings. Safety was evaluated by treatment emergent adverse events (TEAE), discontinuations due to adverse events, vital signs measurements, and clinical laboratory tests. RESULTS: There were statistically significant improvements with duloxetine compared with placebo in IEF (duloxetine baseline 16.4IEF/wk, endpoint 7.7IEF/wk, median percent reduction=50.0% vs placebo baseline 13.3IEF/ wk, endpoint 8.8IEF/wk, median percent reduction=37.1%, p=0.033), and avoidance and limiting behavior subscale (p=0.006) in I-QoL. TEAEs were reported significantly more often in the duloxetine group compared with the placebo group (82.0% vs 31.7%; p<0.001); common AEs (>or=5% in duloxetine-treated subjects and p<0.05) were nausea, dizziness, anorexia, fatigue, lethargy, abdominal discomfort, and constipation. Discontinuation rates because of AEs were 34.4% for duloxetine and 8.3% for placebo. CONCLUSIONS: These data provide evidence for the safety and efficacy of duloxetine for the treatment for Korean women with SUI.
Anorexia
;
Constipation
;
Dizziness
;
Fatigue
;
Female
;
Humans
;
Lethargy
;
Mass Screening
;
Nausea
;
Quality of Life
;
Urinary Incontinence*
;
Vital Signs
;
Duloxetine Hydrochloride
6.Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery
Young hoon JOO ; Jae keun CHO ; Bon seok KOO ; Minsu KWON ; Seong keun KWON ; Soon young KWON ; Min su KIM ; Jeong kyu KIM ; Heejin KIM ; Innchul NAM ; Jong lyel ROH ; Young min PARK ; Il seok PARK ; Jung je PARK ; Sung chan SHIN ; Soon hyun AHN ; Seongjun WON ; Chang hwan RYU ; Tae mi YOON ; Giljoon LEE ; Doh young LEE ; Myung chul LEE ; Joon kyoo LEE ; Jin choon LEE ; Jae yol LIM ; Jae won CHANG ; Jeon yeob JANG ; Man ki CHUNG ; Yuh seok JUNG ; Jae gu CHO ; Yoon seok CHOI ; Jeong seok CHOI ; Guk haeng LEE ; Phil sang CHUNG
Clinical and Experimental Otorhinolaryngology 2019;12(2):107-144
Korean Society of Thyroid-Head and Neck Surgery appointed a Task Force to provide guidance on the implementation of a surgical treatment of oral cancer. MEDLINE databases were searched for articles on subjects related to “surgical management of oral cancer” published in English. Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. The quality of evidence was rated with use RoBANS (Risk of Bias Assessment Tool for Nonrandomized Studies) and AMSTAR (A Measurement Tool to Assess the Methodological Quality of Systematic Reviews). Evidence-based recommendations for practice were ranked according to the American College of Physicians grading system. Additional directives are provided as expert opinions and Delphi questionnaire when insufficient evidence existed. The Committee developed 68 evidence-based recommendations in 34 categories intended to assist clinicians and patients and counselors, and health policy-makers. Proper surgical treatment selection for oral cancer, which is directed by patient- and subsite-specific factors, remains the greatest predictor of successful treatment outcomes. These guidelines are intended for use in conjunction with the individual patient's treatment goals.
Advisory Committees
;
Bias (Epidemiology)
;
Carcinoma, Squamous Cell
;
Counseling
;
Expert Testimony
;
Humans
;
Mouth Neoplasms
;
Neck
;
Republic of Korea